CASSANI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.656
AS - Asia 1.414
EU - Europa 898
SA - Sud America 214
AF - Africa 65
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.250
Nazione #
US - Stati Uniti d'America 1.572
CN - Cina 442
SG - Singapore 419
HK - Hong Kong 187
RU - Federazione Russa 180
VN - Vietnam 165
BR - Brasile 157
IT - Italia 155
IE - Irlanda 151
DE - Germania 125
FR - Francia 73
FI - Finlandia 59
BD - Bangladesh 52
GB - Regno Unito 46
ZA - Sudafrica 38
CA - Canada 36
IN - India 35
MX - Messico 28
AR - Argentina 26
IQ - Iraq 16
JP - Giappone 15
PL - Polonia 14
AT - Austria 11
MA - Marocco 11
NL - Olanda 11
UA - Ucraina 11
ES - Italia 10
SE - Svezia 10
PH - Filippine 9
CL - Cile 8
ID - Indonesia 8
MY - Malesia 8
TR - Turchia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CO - Colombia 6
PK - Pakistan 6
PT - Portogallo 6
SA - Arabia Saudita 6
VE - Venezuela 6
CR - Costa Rica 5
EC - Ecuador 5
JM - Giamaica 5
JO - Giordania 5
LT - Lituania 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
AZ - Azerbaigian 3
CH - Svizzera 3
LV - Lettonia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MN - Mongolia 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
TM - Turkmenistan 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
TW - Taiwan 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.250
Città #
San Jose 269
Singapore 218
Hong Kong 184
Ashburn 155
Dublin 150
Dallas 146
Chandler 124
Beijing 118
New York 77
Ho Chi Minh City 62
Los Angeles 62
Boardman 58
Lauterbourg 55
Munich 51
Redondo Beach 47
Council Bluffs 42
Nanjing 42
Shanghai 40
Johannesburg 36
Milan 36
Hanoi 35
Moscow 30
Jacksonville 29
Turku 23
Frankfurt am Main 22
Princeton 22
Buffalo 21
Helsinki 21
Lawrence 21
Nanchang 21
Wilmington 19
Medford 18
Orem 18
Jiaxing 15
Nuremberg 15
Brooklyn 14
Montreal 14
São Paulo 14
Toronto 14
Warsaw 14
London 12
San Francisco 12
Seattle 12
Boston 11
Changsha 11
Falkenstein 11
Mexico City 11
Rome 11
Santa Clara 11
Shenyang 11
Tokyo 11
Chicago 10
Haiphong 10
Mumbai 10
Pavia 10
Da Nang 9
Amsterdam 8
Düsseldorf 8
Hebei 8
Atlanta 7
Manchester 7
Norwalk 7
Poplar 7
Stockholm 7
Tashkent 7
Brussels 6
Chennai 6
Denver 6
Rio de Janeiro 6
The Dalles 6
Bologna 5
Dhaka 5
Guangzhou 5
Hangzhou 5
Kingston 5
Kuala Lumpur 5
Palermo 5
Phoenix 5
Piscataway 5
Quezon City 5
Tianjin 5
Vienna 5
Ankara 4
Ann Arbor 4
Baghdad 4
Brasília 4
Columbus 4
Curitiba 4
Elk Grove Village 4
Paris 4
Piracicaba 4
Santiago 4
Tallahassee 4
Thái Nguyên 4
Turin 4
Washington 4
Amman 3
Austin 3
Baku 3
Belo Horizonte 3
Totale 2.769
Nome #
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 144
Barbed suture in minimally invasive hysterectomy: a systematic review and meta-analysis 107
Sexuality in premature ovarian insufficiency 102
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis 99
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors? 96
Bilateral ovarian malakoplakia: Case report and review of the literature with clinical and diagnostic considerations 96
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma 96
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 94
Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies 92
Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women? 91
Different local estrogen therapies for a tailored approach to GSM 90
Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer 90
Robotic single-site hysterectomy: Two institutions' preliminary experience 89
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 89
Robotic single-site surgery in management of obese patients with early-stage endometrial cancer 88
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause 86
Robotic single site hysterectomy with bilateral salpingo-oophorectomy in female to male transsexualism. 86
Robotic single-site technique allows pelvic lymphadenectomy in surgical staging of endometrial cancer 86
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 85
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 83
Single-site Versus Multiport Robotic Hysterectomy in Benign Gynecologic Diseases: A Retrospective Evaluation of Surgical Outcomes and Cost Analysis 83
The role of hormone therapy in urogenital health after menopause 83
Current opinion on bevacizumab on endometrial cancer treatment 82
Oxaliplatin for the treatment of ovarian cancer 81
Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience 77
Veliparib for the treatment of ovarian cancer 75
Insights into the vulvar component of the genitourinary syndrome of menopause (GSM) 74
Exploring differences in psychological aspects during pregnancy between cancer survivors and women without a history of cancer 73
The role of fulvestrant in endometrial cancer 70
Robotic single-site surgery for female-to-male transsexuals: preliminary experience. 69
Oral contraception use in BRCA gene mutation carriers: information for counselling in routine clinical practice 67
Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience 66
Intralymphatic Histiocytosis Associated with Tubo-ovarian High-grade Serous Carcinoma: Case Report and Review of the Literature 64
Menopause and endometriosis 64
Four pathogenic variants co-occurring in a MINAS early-onset breast cancer 63
Impact of totally implanted venous access port placement on body image in women with breast cancer 60
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 59
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 58
Long-term risk of malignancy in the neovagina created using colon graft in vaginal agenesis-A case report 57
The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis 56
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy 56
Multiple human papillomavirus infection and high-grade cervical squamous intraepithelial lesions among women with human immunodeficiency virus: a systematic review and a meta-analysis 56
Towards Inclusive Communication in Cancer Prevention and Treatment: A Case Study on Italian Informational Materials 55
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 53
Discourses of Prevention: A Multimodal Study of HPV Vaccination Campaigns in Italy 53
Intralesional hemorrhage in Krukenberg tumor: A case report and review of the literature 53
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 52
Psychological Well-Being, Prenatal Attachment, and Quality of Early Mother-Infant Interaction: A Pilot Study With a Sample of Mothers With or Without Cancer History 51
Surveillance alone in stage i malignant ovarian germ cell tumors: A MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 46
RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers 46
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms 46
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 44
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 41
Motherhood during or after breast cancer diagnosis: A qualitative study 40
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): The MITO-9 study 38
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 38
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 37
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 37
Ovarian cancer onset across different BRCA mutation types: A view to a more tailored approach for BRCA mutated patients 37
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 36
Term pregnancy and mode of delivery 36
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project 32
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 29
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 27
null 5
Beyond the placebo effect: a systematic review and a network meta-analysis of treatment strategies for vulvodynia 4
Sexual function after menopause: the role of vaginal estrogens 4
A meta-umbrella review of risk factors for vulvodynia: evidence from demographic, psychosocial, and biomedical domains 2
Sexual health in women and sexual-gender-minority patients with cancer: A nationwide survey on healthcare professional awareness and attitude on behalf of MITO and AIRO-gynecology group 1
Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY) 1
Totale 4.326
Categoria #
all - tutte 18.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.473


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202294 0 0 6 0 1 5 1 6 7 1 14 53
2022/2023361 28 40 1 17 26 35 0 22 166 3 17 6
2023/2024285 7 38 7 13 10 60 7 16 2 9 16 100
2024/2025965 34 63 12 12 7 78 40 72 252 61 110 224
2025/20262.377 202 160 185 228 305 111 401 100 245 236 122 82
Totale 4.326